Supportive care during aldesleukin therapy for patients infected with human immunodeficiency virus.
Gabriel
C M
CM
Washington Hospital Center, Washington, DC, USA.
Minor
J R
JR
Vogel
S
S
Piscitelli
S C
SC
D000082:Acetaminophen / Q000191:economics / Q000627:therapeutic use; D000328:Adult; D018712:Analgesics, Non-Narcotic / Q000191:economics / Q000627:therapeutic use; D000932:Antiemetics / Q000191:economics / Q000627:therapeutic use; D005260:Female; D005334:Fever / Q000139:chemically induced / Q000188:drug therapy / Q000191:economics; D015658:HIV Infections / Q000191:economics / Q000628:therapy*; D006801:Humans; D007052:Ibuprofen / Q000191:economics / Q000627:therapeutic use; D007376:Interleukin-2 / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000191:economics / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced / Q000188:drug therapy / Q000191:economics; D017294:Ondansetron / Q000191:economics / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use; D012189:Retrospective Studies; D014839:Vomiting / Q000139:chemically induced / Q000188:drug therapy / Q000191:economics
D018712:Analgesics, Non-Narcotic; D000932:Antiemetics; D007376:Interleukin-2; D011994:Recombinant Proteins; D000082:Acetaminophen; D017294:Ondansetron; C082598:aldesleukin; D007052:Ibuprofen